Nordea Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.87M | Buy |
21,257
+1,916
| +10% | +$176K | ﹤0.01% | 756 |
|
|
2025
Q4 | $1.74M | Buy |
19,341
+26
| +0.1% | +$2.46K | ﹤0.01% | 771 |
|
|
2025
Q3 | $1.89M | Buy |
19,315
+1,476
| +8% | +$146K | ﹤0.01% | 750 |
|
|
2025
Q2 | $1.63M | Buy |
17,839
+1,210
| +7% | +$117K | ﹤0.01% | 757 |
|
|
2025
Q1 | $1.88M | Buy |
16,629
+296
| +2% | +$31.7K | ﹤0.01% | 711 |
|
|
2024
Q4 | $1.73M | Buy |
16,333
+609
| +4% | +$65.3K | ﹤0.01% | 707 |
|
|
2024
Q3 | $1.7M | Hold |
15,724
| – | – | ﹤0.01% | 724 |
|
|
2024
Q2 | $1.7M | Buy |
15,724
+570
| +4% | +$67.2K | ﹤0.01% | 723 |
|
|
2024
Q1 | $2.01M | Buy |
15,154
+1,551
| +11% | +$194K | ﹤0.01% | 710 |
|
|
2023
Q4 | $1.66M | Sell |
13,603
-17,367
| -56% | -$1.94M | ﹤0.01% | 739 |
|
|
2023
Q3 | $3.52M | Sell |
30,970
-371
| -1% | -$47.1K | ﹤0.01% | 582 |
|
|
2023
Q2 | $4.61M | Sell |
31,341
-994
| -3% | -$135K | 0.01% | 524 |
|
|
2023
Q1 | $4.15M | Sell |
32,335
-15,326
| -32% | -$1.92M | 0.01% | 558 |
|
|
2022
Q4 | $6.06M | Sell |
47,661
-508
| -1% | -$59K | 0.01% | 468 |
|
|
2022
Q3 | $5.18M | Sell |
48,169
-15,719
| -25% | -$1.72M | 0.01% | 509 |
|
|
2022
Q2 | $6.62M | Sell |
63,888
-1,862,797
| -97% | -$221M | 0.01% | 457 |
|
|
2022
Q1 | $249M | Sell |
1,926,685
-957,904
| -33% | -$115M | 0.31% | 91 |
|
|
2021
Q4 | $358M | Sell |
2,884,589
-17,515
| -0.6% | -$2.29M | 0.43% | 61 |
|
|
2021
Q3 | $422M | Buy |
2,902,104
+1,165,535
| +67% | +$171M | 0.55% | 45 |
|
|
2021
Q2 | $271M | Buy |
1,736,569
+16,749
| +1% | +$2.71M | 0.36% | 76 |
|
|
2021
Q1 | $272M | Sell |
1,719,820
-159,465
| -8% | -$24.7M | 0.39% | 64 |
|
|
2020
Q4 | $281M | Sell |
1,879,285
-531,755
| -22% | -$75.1M | 0.45% | 56 |
|
|
2020
Q3 | $314M | Sell |
2,411,040
-3,855,150
| -62% | -$504M | 0.59% | 44 |
|
|
2020
Q2 | $708M | Buy |
6,266,190
+2,977,306
| +91% | +$343M | 0.73% | 36 |
|
|
2020
Q1 | $316M | Buy |
3,288,884
+357,298
| +12% | +$46.8M | 0.76% | 33 |
|
|
2019
Q4 | $424M | Sell |
2,931,586
-83,211
| -3% | -$11.5M | 0.85% | 32 |
|
|
2019
Q3 | $399M | Sell |
3,014,797
-77,910
| -3% | -$10.1M | 0.87% | 32 |
|
|
2019
Q2 | $354M | Sell |
3,092,707
-73,353
| -2% | -$8.59M | 0.79% | 32 |
|
|
2019
Q1 | $393M | Sell |
3,166,060
-699,320
| -18% | -$79.5M | 0.82% | 33 |
|
|
2018
Q4 | $389M | Sell |
3,865,380
-384,312
| -9% | -$43.2M | 0.92% | 29 |
|
|
2018
Q3 | $542M | Sell |
4,249,692
-229,201
| -5% | -$27.3M | 1.12% | 20 |
|
|
2018
Q2 | $485M | Sell |
4,478,893
-568,819
| -11% | -$61.9M | 1.16% | 21 |
|
|
2018
Q1 | $534M | Sell |
5,047,712
-126,558
| -2% | -$14.7M | 1.28% | 20 |
|
|
2017
Q4 | $606M | Sell |
5,174,270
-261,720
| -5% | -$29.6M | 1.43% | 18 |
|
|
2017
Q3 | $618M | Buy |
5,435,990
+368,021
| +7% | +$42.5M | 1.49% | 17 |
|
|
2017
Q2 | $632M | Sell |
5,067,969
-11,250
| -0.2% | -$1.33M | 1.59% | 15 |
|
|
2017
Q1 | $602M | Buy |
5,079,219
+1,017,020
| +25% | +$115M | 1.59% | 14 |
|
|
2016
Q4 | $407M | Sell |
4,062,199
-172,775
| -4% | -$18.5M | 1.08% | 27 |
|
|
2016
Q3 | $535M | Buy |
4,234,974
+24,712
| +0.6% | +$3.05M | 1.38% | 18 |
|
|
2016
Q2 | $492M | Buy |
4,210,262
+233,274
| +6% | +$26.4M | 1.38% | 20 |
|
|
2016
Q1 | $412M | Buy |
3,976,988
+302,087
| +8% | +$29.2M | 1.24% | 22 |
|
|
2015
Q4 | $366M | Sell |
3,674,901
-125,933
| -3% | -$12.3M | 1.24% | 22 |
|
|
2015
Q3 | $347M | Sell |
3,800,834
-117,882
| -3% | -$11.8M | 1.28% | 20 |
|
|
2015
Q2 | $416M | Buy |
3,918,716
+644,013
| +20% | +$71.3M | 1.46% | 16 |
|
|
2015
Q1 | $374M | Buy |
3,274,703
+56,947
| +2% | +$6.5M | 1.34% | 20 |
|
|
2014
Q4 | $354M | Buy |
3,217,756
+281,921
| +10% | +$29.7M | 1.31% | 20 |
|
|
2014
Q3 | $287M | Sell |
2,935,835
-609,638
| -17% | -$60M | 1.15% | 25 |
|
|
2014
Q2 | $358M | Sell |
3,545,473
-777,975
| -18% | -$75.9M | 1.49% | 17 |
|
|
2014
Q1 | $397M | Buy |
4,323,448
+16,881
| +0.4% | +$1.56M | 1.85% | 10 |
|
|
2013
Q4 | $390M | Buy |
4,306,567
+28,898
| +0.7% | +$2.5M | 1.94% | 9 |
|
|
2013
Q3 | $341M | Buy |
4,277,669
+237,022
| +6% | +$18.7M | 1.9% | 10 |
|
|
2013
Q2 | $294M | Buy |
+4,040,647
| New | +$302M | 1.82% | 13 |
|
Other funds holding ZBH
VCM
VPM
Nordea Investment Management's ZBH Position: Q1 2026 in Review
Nordea Investment Management increased its Zimmer Biomet (ZBH) stake by 9.9% in Q1 2026, buying an estimated $176K and bringing the position to 21,257 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #756.
Nordea Investment Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $708M in Q2 2020. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Nordea Investment Management held 21,257 shares of Zimmer Biomet worth $1.87M as of Q1 2026.
- Nordea Investment Management bought 1,916 Zimmer Biomet shares in Q1 2026, an estimated $176K.
- Zimmer Biomet made up ﹤0.01% of Nordea Investment Management's portfolio in Q1 2026, its #756 holding.
- Nordea Investment Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Nordea Investment Management's Zimmer Biomet position peaked at $708M in Q2 2020.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.